Taking advantage of CD44 overexpression on the surface of most tumor cells and high levels of GSH in tumor microenvironment [25–28], the nanosystem could be specifically uptake by breast cancer cells and rapidly degrade and release functional cargoes (β-lap, CaO2 and Fe2+) in response to intracellular GSH. Here, CD44 is linked to neoplasm.